Mitochondria and Disease:
The Missing Link in Modern Health
Most chronic conditions don’t start at the organ level.
They start at the level of cellular energy.
Table of Contents
Introduction
Mitochondria are tiny structures inside nearly every cell in your body. They help produce the energy your cells need to function, while also helping regulate metabolism, oxidative stress, and other core processes. When mitochondria work well, cells perform better. When they do not, energy drops, stress rises, and cellular function becomes less stable.
Mitochondrial dysfunction is now being recognized as more than a rare inherited problem. It appears across many of today’s most common chronic conditions, including metabolic disease, neurodegeneration, women’s health conditions, cancer, and autoimmune disorders.
Below, you will find an evidence-based table of 21 major diseases and conditions in which mitochondrial health plays a documented role.
Following the table, you will find in-depth sections for every condition. Written for an educated reader, each deep dive explains:
- What the disease actually is
- How it changes daily life
- The real-world side effects and limitations of today’s leading treatments
- The specific scientific connection to mitochondrial dysfunction
Table: Diseases Ranked by Prevalence
| Disease Name | Estimated Patients Globally | Current Top Treatment | Approx. Annual Treatment Cost (US) | Correlation to Mitochondrial Health |
|---|---|---|---|---|
| Dyslipidemia (incl. hypercholesterolemia & metabolic syndrome) |
1,500+ million | Statins + lifestyle | <$500 | उच्च |
| MASLD / MASH (fatty liver disease spectrum) |
1,270 million | Lifestyle + resmetirom for advanced MASH | $47,000 (advanced cases) | Very high |
| Obesity | 1,000 million | GLP-1 receptor agonists | ~$16,000 | उच्च |
| Menopause-Related Conditions | 1,000+ million | HRT + non-hormonal options + lifestyle | $200–$2,000 | उच्च |
| Chronic Kidney Disease (cardiorenal axis) |
788 million | RAAS inhibitors + SGLT2i ± dialysis | Variable, dialysis >$80,000 | उच्च |
| Type 2 Diabetes Mellitus | 590 million | Metformin + GLP-1 receptor agonists | $100–$15,000 | Very high |
| Ischemic Stroke & Reperfusion Injury | 100 million | Antiplatelets, statins, thrombolysis + rehab | Variable | उच्च |
| Polycystic Ovary Syndrome (PCOS) |
70 million | Lifestyle, metformin, oral contraceptives, letrozole | $1,000–$5,000 | उच्च |
| Heart Failure (incl. cardiomyopathy) |
64 million | Guideline-directed medical therapy | $5,000–$20,000+ | Very high |
| Autism Spectrum Disorder | 62 million | Behavioral and supportive therapies | Variable | Medium |
| Alzheimer’s Disease | 57 million | Symptomatic drugs + anti-amyloid therapies | $26,000+ | Very high |
| Cancer (broad malignancies) |
53.5 million | Immunotherapy, targeted therapy, chemotherapy, radiation | $50,000–$300,000+ | उच्च |
| ME/CFS (chronic fatigue syndrome) |
25 million | Supportive / symptomatic care | Low | उच्च |
| Parkinson’s Disease | 12 million | Levodopa / dopaminergic therapies | $1,000–$5,000 | Very high |
| Autoimmune Diseases (SLE, RA, Sjögren’s) |
5 million (SLE representative) | Immunosuppressants / biologics | $10,000–$50,000 | Medium |
| Multiple Sclerosis | 2.8 million | Disease-modifying therapies | $60,000–$100,000 | Medium-High |
| Primary Mitochondrial Diseases | 2 million | Supportive care + targeted agents | >$50,000 | Very high |
| Hepatocellular Carcinoma | 1 million | Systemic therapy | $100,000–$200,000+ | उच्च |
| Amyotrophic Lateral Sclerosis (ALS) |
0.35 million | Riluzole / edaravone | $10,000–$150,000 | उच्च |
| Huntington’s Disease | 0.07 million | Symptomatic treatment | Variable | उच्च |
| Friedreich’s Ataxia | 0.05 million | Supportive care | Low–moderate | Very high |
Dyslipidemia (incl. hypercholesterolemia & metabolic syndrome)
What is this disease?
Dyslipidemia is an imbalance in blood lipids, typically high LDL cholesterol, high triglycerides, and/or low HDL. When combined with abdominal obesity, high blood pressure, and elevated fasting glucose, it becomes metabolic syndrome. It is a silent condition that quietly damages arteries over years.
How it affects lifestyle
Many people feel fine until a heart attack or stroke occurs. Daily life often involves strict dietary limits, regular exercise, and lifelong medication. Fatigue, brain fog, and reduced exercise tolerance are common even before clinical events.
Side effects of current treatments
Statins can cause muscle pain (myalgia), weakness, elevated liver enzymes, and in rare cases rhabdomyolysis. Long-term use is also linked to modest increases in new-onset diabetes and cognitive complaints in some patients.
The correlation between mitochondrial health and this disease
Mitochondrial dysfunction is a primary driver. Impaired β-oxidation in hepatic mitochondria leads to excess triglyceride accumulation and VLDL secretion. Elevated ROS from dysfunctional electron transport chain (ETC) complexes oxidizes LDL particles, making them more atherogenic. Nuclear and mtDNA damage further reduces PGC-1α expression, the master regulator of mitochondrial biogenesis,
creating a vicious cycle of lipid dysregulation and inflammation.
Selected Scientific Papers
- Ramirez-Sanchez I, et al. Stimulatory Effects of (+)-Epicatechin on Mitochondrial Biogenesis and Function in Skeletal Muscle of Aged Rats: Underlying Mechanisms. J Med Food., 2026.
- Moreno-Ulloa A, et al. (including Ceballos G). Effects of (−)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins. Bioorg Med Chem Lett., 2013.
- Pliouta L, et al. Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review. Journal of Clinical Medicine, 2025.
- Stańczyk M, et al. Mitochondrial Dysfunctions: Genetic and Cellular Implications Revealed by Various Model Organisms. Genes, 2024.
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD/MASH)
What is this disease?
MASLD (formerly NAFLD) is excessive fat buildup in the liver without heavy alcohol use. When inflammation and hepatocyte injury develop, it progresses to MASH (formerly NASH) and can lead to fibrosis, cirrhosis, or liver cancer.
How it affects lifestyle
Patients often experience persistent fatigue, right-upper quadrant discomfort, and reduced stamina. Weight loss is difficult; many report “feeling old” and limit physical activity to avoid discomfort.
Side effects of current treatments
Lifestyle is first-line but hard to sustain. Resmetirom can cause gastrointestinal upset, diarrhea, and nausea. Advanced cases may require biopsy monitoring and carry risks from eventual transplant.
The correlation between mitochondrial health and this disease
Very high correlation. Hepatic mitochondria are the primary site of fatty-acid oxidation. Defective ETC complexes I and III increase ROS, impair ATP production, and activate JNK and NF-κB pathways that drive inflammation and stellate-cell activation. mtDNA depletion and reduced mitophagy are documented in biopsy studies of progressing MASH.
Selected Scientific Papers
- Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial dysfunction in nonalcoholic fatty liver disease: from organelle dysfunction to clinical disease. J Hepatol. 2013
- Sunny NE, Bril F, Cusi K. Mitochondrial adaptation and dysfunction in nonalcoholic fatty liver disease. Cell Metab. 2017
- García-Ruiz I, Solís-Muñoz P, Fernández-Moreira D, et al. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Radic Res. 2013
- Lin CW, Zhang H, Li M, et al. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J Hepatol. 2013
Obesity
What is this disease?
Obesity is excessive body-fat accumulation that impairs health. It is now understood as a chronic metabolic disorder driven by energy imbalance and inflammation.
How it affects lifestyle
Daily activities become physically taxing; joint pain, breathlessness, and low energy limit mobility and social engagement. Mental health impacts (depression, stigma) are common.
Side effects of current treatments
GLP-1 agonists cause nausea, vomiting, diarrhea, and muscle loss (“Ozempic face/body”). Long-term adherence is challenging; weight regain is frequent upon discontinuation.
The correlation between mitochondrial health and this disease
High correlation. Adipose and skeletal-muscle mitochondria show reduced biogenesis, impaired fatty-acid oxidation, and elevated ROS, perpetuating insulin resistance and inflammation. Defective mitophagy further traps cells in a low energy, pro-inflammatory state.
Selected Scientific Papers
- Heinonen S, et al. Impaired Mitochondrial Biogenesis in Adipose Tissue in Acquired Obesity. Diabetes, 2015.
- Ritov VB, et al. Deficiency of Subsarcolemmal Mitochondria in Obesity and Type 2 Diabetes. Diabetes, 2005.
- Lefranc C, et al. Mitochondrial Oxidative Stress in Obesity:role of the mineralocorticoid receptor. Journal of Endocrinology, 2018.
- de Mello AH, et al. Mitochondrial Dysfunction in Obesity. Life Sciences, 2018.
Menopause-Related Conditions
What is this disease?
Menopause is the permanent cessation of menstruation accompanied by declining estrogen. It triggers vasomotor symptoms, metabolic shifts, mood changes, sarcopenia, and increased osteoporosis risk.
How it affects lifestyle
Hot flashes, night sweats, sleep disruption, brain fog, weight gain, and reduced muscle strength dramatically affect quality of life, work performance, and relationships.
Side effects of current treatments
HRT carries risks of breast cancer, stroke, and thrombosis in some women. Nonhormonal options (e.g., fezolinetant) can cause liver enzyme elevation or limited efficacy on metabolic symptoms.
The correlation between mitochondrial health and this disease
High correlation. Estrogen decline directly impairs mitochondrial function in brain, muscle, and adipose tissue via reduced PGC-1α and ERβ signaling, leading to ROS accumulation, energy deficits, and accelerated sarcopenia/metabolic syndrome.
Selected Scientific Papers
- Klinge CM. Estrogenic control of mitochondrial function. Redox Biol. 2020.
- Gupte AA, Pownall HJ, Hamilton DJ. Estrogen: an emerging regulator of insulin action and mitochondrial function. J Diabetes Res. 2015.
- Schreiber SN, Emter R, Hock MB, et al. The estrogen-related receptor α (ERRα) functions in PGC-1α-induced mitochondrial biogenesis. Proc Natl Acad Sci U S A. 2004.
- Pellegrino A, Tiidus PM, Vandenboom R. Mechanisms of Estrogen Influence on Skeletal Muscle: Mass, Regeneration, and Mitochondrial Function. Sports Medicine, 2022.
Type 2 Diabetes Mellitus (incl. cutaneous complications)
What is this disease?
T2DM is chronic hyperglycemia due to insulin resistance and β-cell dysfunction, with skin complications (ulcers, infections) from microvascular damage.
How it affects lifestyle
Frequent blood-glucose monitoring, dietary vigilance, fatigue, neuropathy, and wound-care burdens reduce mobility and independence.
Side effects of current treatments
GLP-1s cause GI distress and muscle loss; metformin can cause GI upset and rare lactic acidosis.
The correlation between mitochondrial health and this disease
Very high correlation. Pancreatic and muscle mitochondria show impaired OXPHOS, ROS overload, and reduced biogenesis, directly contributing to insulin resistance and β-cell failure.
Selected Scientific Papers
- Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes. Nature Reviews Endocrinology, 2011.
- Montgomery MK, Turner N. Mitochondrial dysfunction and insulin resistance: an update. Endocrine Connections, 2015.
- Anderson EJ, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. JCI, 2009.
- Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic β-cells. Nature, 2001.
Ischemic Stroke & Reperfusion Injury
What is this disease?
Ischemic stroke occurs when a blood clot blocks brain blood flow; reperfusion injury happens when blood supply is restored and triggers secondary damage.
How it affects lifestyle
Sudden paralysis, speech loss, cognitive deficits, and long-term rehabilitation dominate daily life, often requiring caregivers and major lifestyle adjustments.
Side effects of current treatments
Thrombolytics and antiplatelets increase bleeding risk; statins can cause muscle and liver issues; rehabilitation is physically exhausting.
The correlation between mitochondrial health and this disease
High correlation. During ischemia and reperfusion, mitochondria generate massive ROS bursts, open the permeability transition pore, and trigger neuronal cell death via cytochrome c release and apoptosis.
Selected Scientific Papers
- Liu F, Lu J, Manaenko A, Tang J, Hu Q. Mitochondria in ischemic stroke: new insight and implications. Aging and Disease, 2018.
- Zhu Y, et al. Mitochondrial MPTP: A novel target of ethnomedicine for stroke treatment by apoptosis inhibition. Frontiers in Pharmacology (via PMC), 2020.
- Sanders R, et al. Chemical conditioning as an approach to ischemic stroke tolerance: mitochondria as the target. International Journal of Molecular Sciences, 2016.
- Lee SR, et al. Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation. Antioxidants & Redox Signaling, Biochim Biophys Acta, 2012.
Polycystic Ovary Syndrome (PCOS)
What is this disease?
PCOS is a hormonal disorder causing irregular periods, excess androgens, and polycystic ovaries, often with insulin resistance.
How it affects lifestyle
Infertility, weight gain, acne, hair loss, and mood swings create significant emotional and physical burdens.
Side effects of current treatments
Metformin causes GI upset; oral contraceptives increase thrombosis risk; infertility treatments are costly and stressful.
The correlation between mitochondrial health and this disease
High correlation. Ovarian and muscle mitochondria exhibit impaired biogenesis and elevated ROS, worsening insulin resistance and hyperandrogenism.
Selected Scientific Papers
- Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights.” Journal of the Chinese Medical Association, 2025.
- Mitochondrial Dysfunction in PCOS: Insights into Reproductive Organ Pathophysiology. Int J Mol Sci., 2023.
- A Comprehensive Review of the Contribution of Mitochondrial DNA Mutations and Dysfunction in Polycystic Ovary Syndrome. International Journal of Molecular Sciences, 2025.
- Genetic associations with polycystic ovary syndrome: the role of the mitochondrial genome. Journal of Clinical Pathology, 2022.
Chronic Kidney Disease (cardiorenal axis)
What is this disease?
CKD is progressive loss of kidney function, often intertwined with heart disease in the cardiorenal syndrome.
How it affects lifestyle
Fatigue, fluid retention, dietary restrictions, frequent medical visits, and in advanced stages dialysis or transplant dominate daily life.
Side effects of current treatments
RAAS inhibitors and SGLT2i can cause hyperkalemia or volume depletion. Dialysis is physically and emotionally taxing with high infection risk.
The correlation between mitochondrial health and this disease
High correlation. Renal tubular mitochondria are highly energy-demanding; ETC dysfunction and ROS drive fibrosis, podocyte injury, and progression to end-stage disease.
Selected Scientific Papers
- Galvan DL, Green NH, Danesh FR. The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney International, 2017.
- Hall AM, Unwin RJ. The not so “mighty chondrion”: emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiology, 2007.
- Kang HM, Ahn SH, Choi P, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nature Medicine, 2015.
- Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nature Reviews Nephrology, 2017.
Heart Failure (incl. cardiomyopathy)
What is this disease?
Heart failure is the heart’s inability to pump blood effectively, often due to weakened cardiac muscle.
How it affects lifestyle
Shortness of breath, fatigue, fluid retention, and frequent hospitalizations limit daily activities and independence.
Side effects of current treatments
GDMT can cause hypotension, kidney issues, or electrolyte imbalance; device therapies require surgery.
The correlation between mitochondrial health and this disease
Very high correlation. Cardiac mitochondria show reduced ATP production, ROS overload, and impaired calcium handling, directly driving contractile dysfunction.
Selected Scientific Papers
- Brown DA, et al. Mitochondrial function as a therapeutic target in heart failure. Nature Reviews Cardiology, 2017.
- Dorn GW 2nd. Mitochondrial dynamics in heart disease. Front Cell Dev Biol., 2019.
- Rosca MG, Hoppel CL. Mitochondrial dysfunction in heart failure. Heart Failure Reviews. 2013
- Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci U S A. 2015
Autism Spectrum Disorder
What is this disease?
Autism spectrum disorder is a neurodevelopmental condition characterized by differences in social communication, repetitive behaviors, and sensory processing.
How it affects lifestyle
Daily routines can be challenging due to sensory sensitivities, communication barriers, and the need for structured support; families often face significant caregiving demands.
Side effects of current treatments
Behavioral therapies are time-intensive with variable outcomes; medications for co-occurring symptoms (e.g., irritability) can cause sedation, weight gain, or metabolic changes.
The correlation between mitochondrial health and this disease
Medium correlation. Many individuals with ASD show mitochondrial dysfunction including impaired OXPHOS, elevated ROS, and mtDNA abnormalities, contributing to neuroinflammation and energy deficits in the developing brain.
Selected Scientific Papers
Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Molecular Psychiatry. 2012
Frye RE, Rossignol DA. Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatric Research. 2011
Giulivi C, Zhang YF, Omanska-Klusek A, et al. Mitochondrial dysfunction in autism. JAMA. 2010
Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006
Alzheimer’s Disease
What is this disease?
Alzheimer’s disease is a progressive neurodegenerative disorder causing memory loss, cognitive decline, and behavioral changes.
How it affects lifestyle
Patients gradually lose independence in daily tasks, driving, finances, and social interactions; caregivers experience high emotional and physical burden.
Side effects of current treatments
Cholinesterase inhibitors and anti-amyloid antibodies can cause nausea, brain swelling, or limited slowing of decline; long-term efficacy remains modest.
The correlation between mitochondrial health and this disease
Very high correlation. Amyloid and tau pathology impair mitochondrial transport, ETC function, and calcium buffering, leading to synaptic failure and neuronal death via ROS and energy collapse.
Selected Scientific Papers
Reddy PH. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease. Experimental Neurology. 2009.
Wang X, Su B, Lee HG, et al. Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. Journal of Neuroscience. 2009.
Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer’s disease. Journal of Alzheimer’s Disease. 2018.
Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochimica et Biophysica Acta. 2010.
Cancer (broad malignancies)
What is this disease?
Cancer encompasses many diseases in which cells grow uncontrollably due to genetic mutations, often forming tumors that can spread.
How it affects lifestyle
Treatment regimens (surgery, chemo, radiation) cause fatigue, pain, nausea, and frequent medical visits; survivors face long-term monitoring and lifestyle adjustments.
Side effects of current treatments
Immunotherapy and TKIs can trigger immune-related toxicities; chemotherapy causes hair loss, neuropathy, and immunosuppression.
The correlation between mitochondrial health and this disease
High correlation. Tumor cells reprogram mitochondrial metabolism (Warburg effect) to support rapid proliferation while resisting apoptosis; elevated ROS and mtDNA mutations drive genomic instability and therapy resistance.
Selected Scientific Papers
- Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of Cancer: The Next Generation. Cell.
- Bower, J. E. (2014). Cancer-related fatigue: Mechanisms, risk factors, and treatments. Nat Rev Clin Oncol.
- Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018). Immune-related adverse events associated with immune checkpoint blockade. New England Journal of Medicine.
- Crawford, J., et al. (2024). The impact of myelosuppression on quality of life… (PMC).
- Du, H., et al. (2025). Mitochondrial metabolism and cancer therapeutic innovation. Signal Transduction and Targeted Therapy. (Nature)
Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (ME/CFS)
What is this disease?
ME/CFS is a complex, long-term illness causing profound fatigue that is not improved by rest and worsens with activity.
How it affects lifestyle
Even simple tasks like showering or reading can trigger post-exertional malaise; patients often become housebound or bedbound.
Side effects of current treatments
Supportive care (pacing, cognitive behavioral therapy) has limited impact; no approved disease-modifying drugs exist.
The correlation between mitochondrial health and this disease
High correlation. Muscle and immune-cell mitochondria show reduced ATP production and impaired OXPHOS, directly correlating with the hallmark fatigue and energy deficits.
Selected Scientific Papers
- Grach, S. L., et al. (2023). Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clinic Proceedings.
- Conroy, K., et al. (2021). Homebound versus Bedridden Status among Those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (PMC)
- Sanal-Hayes, N. E. M., et al. (2023). A scoping review of “Pacing” for management of ME/CFS. (PMC)
- Tomas, C., et al. (2017). Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. (PMC)
Parkinson’s Disease
What is this disease?
Parkinson’s disease is a progressive movement disorder caused by loss of dopamine-producing neurons.
How it affects lifestyle
Tremor, stiffness, and slow movement make walking, writing, and daily self-care increasingly difficult; non-motor symptoms (depression, sleep issues) add burden.
Side effects of current treatments
Levodopa can cause dyskinesias and “on-off” fluctuations; deep-brain stimulation requires surgery.
The correlation between mitochondrial health and this disease
Very high correlation. Mitochondrial complex I dysfunction and ROS accumulation are central to dopaminergic neuron death; mtDNA mutations accelerate disease progression.
Selected Scientific Papers
- Kalia, L. V., & Lang, A. E. (2015). Parkinson’s disease. The Lancet.
- Jankovic, J. (2008). Parkinson’s disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry.
- Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018). Immune-related adverse events associated with immune checkpoint blockade. NEJM.
- Schapira, A. H. V., et al. (1990). Mitochondrial complex I deficiency in Parkinson’s disease. (PubMed)
Autoimmune Diseases (SLE, RA, Sjögren’s)
What is this disease?
Autoimmune diseases occur when the immune system mistakenly attacks healthy tissues, causing chronic inflammation.
How it affects lifestyle
Flare-ups bring pain, fatigue, and organ involvement; patients manage lifelong medication and activity limitations.
Side effects of current treatments
Immunosuppressants and biologics increase infection risk and can cause organ toxicity.
The correlation between mitochondrial health and this disease
Medium correlation. Mitochondrial ROS and damaged mtDNA act as danger signals
that amplify immune activation and tissue inflammation.
Selected Scientific Papers
- Song, X., et al. (2025). Autoimmune Diseases: Molecular Pathogenesis and … (review, PMC).
- Elefante, E., et al. (2020). Impact of fatigue on health-related quality of life and illness perception in systemic lupus erythematosus. RMD Open.
- Singh, J. A., Cameron, C., Noorbaloochi, S., et al. (2015). The risk of serious infection with biologics in treating patients with rheumatoid arthritis: a systematic review and meta-analysis. (Lancet)
- Grazioli, S., Pugin, J., & colleagues (2018). Mitochondrial Damage-Associated Molecular Patterns and… Frontiers in Immunology.
Multiple Sclerosis
What is this disease?
Multiple sclerosis (MS) is an autoimmune condition in which the immune system attacks myelin in the central nervous system.
How it affects lifestyle
Vision loss, weakness, numbness, and fatigue lead to mobility aids, workplace accommodations, and unpredictable symptom flares.
Side effects of current treatments
Disease-modifying therapies can cause injection-site reactions, infections, or progressive multifocal leukoencephalopathy risk.
The correlation between mitochondrial health and this disease
Medium–high correlation. Evidence suggests mitochondrial dysfunction and energy failure in demyelinated axons can contribute to axonal degeneration and progressive disability in MS.
Selected Scientific Papers
- Wu, G. F., & Alvarez, E. (2011). The immuno-pathophysiology of multiple sclerosis. Nature Reviews Neurology.
- Ghasemi, N., Razavi, S., & Nikzad, E. (2017). Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell Journal (Yakhteh). (PMC)
- Bloomgren, G., et al. (2012). Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. New England Journal of Medicine.
- Su, K. G., et al. (2009). Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis. (PMC)
Primary Mitochondrial Diseases (aggregate)
What is this disease?
Primary mitochondrial diseases are rare genetic disorders caused by mutations in mtDNA or nuclear genes affecting mitochondrial function.
How it affects lifestyle
Multisystem involvement leads to muscle weakness, vision/hearing loss, seizures, and developmental delays; lifelong medical management is required.
Side effects of current treatments
Supportive care and targeted agents (e.g., idebenone) have limited efficacy; many patients rely on symptom relief only.
The correlation between mitochondrial health and this disease
Very high correlation. Primary mitochondrial diseases are defined by genetic defects that impair mitochondrial energy metabolism, often involving oxidative phosphorylation and ATP-generating capacity, with downstream effects on redox balance and multisystem function.
Selected Scientific Papers
- Chinnery, P. F. (2021). Primary Mitochondrial Disorders Overview. GeneReviews.
- Falk, M. J., et al. (2010). Neurodevelopmental Manifestations of Mitochondrial Disease. (review, PMC).
- Klopstock, T., et al. (2011). A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. (RHODOS trial).
- Wen, H., et al. (2025). Mitochondrial diseases: from molecular mechanisms to … (review, Nature portfolio)
Hepatocellular Carcinoma
What is this disease?
Hepatocellular carcinoma is the most common primary liver cancer, often arising from chronic liver disease such as MASLD/MASH.
How it affects lifestyle
Fatigue, abdominal pain, weight loss, and treatment side effects significantly reduce quality of life; advanced stages require palliative care.
Side effects of current treatments
Systemic therapies cause fatigue, hypertension, and immune-related toxicities; liver transplant is limited by donor availability.
The correlation between mitochondrial health and this disease
High correlation. Mitochondrial metabolic reprogramming and ROS drive tumor progression from MASLD background.
Selected Scientific Papers
- Ma, Y., et al. (2024). A review of MASLD-related hepatocellular carcinoma. (review, PMC)
- Norman, E. M. L., et al. (2022). Hepatocellular carcinoma and its impact on quality of life. (review, PMC)
- Finn, R. S., et al. (2020). Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. New England Journal of Medicine
- Sapisochin, G., & Bruix, J. (2016). Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nature Reviews Gastroenterology & Hepatology.
- Meroni, M., et al. (2025). Exploring multiorgan mitochondrial dysfunction in the switch toward progressive MASLD in AMLN mice. iScience
Amyotrophic Lateral Sclerosis (ALS)
What is this disease?
ALS, commonly known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that destroys motor neurons, leading to muscle weakness and paralysis.
How it affects lifestyle
Loss of movement, speech, and swallowing function requires assistive devices and full-time caregiving; life expectancy is typically 2–5 years.
Side effects of current treatments
Riluzole and edaravone offer modest slowing of decline but can cause liver toxicity or fatigue.
The correlation between mitochondrial health and this disease
High correlation. Motor-neuron mitochondria show defective transport, calcium overload, and ROS-mediated apoptosis.
Selected Scientific Papers
- Zarei, S., Carr, K., Reiley, L., et al. (2015). A comprehensive review of amyotrophic lateral sclerosis. (PMC)
- Vasta, R., et al. (2025). Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis… (PMC)
- Prado Jr, M., et al. (2025). Disease-modifying therapies in amyotrophic lateral sclerosis: a network meta-analysis of randomized clinical trials. Canadian Journal of Neurological Sciences
- Guan, S., et al. (2025). Comparative safety analysis of Riluzole, Edaravone… (PMC)
- Smith, E. F., et al. (2019). The role of mitochondria in amyotrophic lateral sclerosis. Neuroscience Letters
Huntington’s Disease
What is this disease?
Huntington’s disease is an inherited neurodegenerative disorder causing uncontrolled movements, cognitive decline, and psychiatric symptoms.
How it affects lifestyle
Chorea, depression, and progressive dementia require constant supervision; family members often face genetic counseling decisions.
Side effects of current treatments
Symptomatic drugs (e.g., tetrabenazine) can cause depression or sedation; no disease-modifying therapy exists.
The correlation between mitochondrial health and this disease
High correlation. Mutant huntingtin protein impairs mitochondrial trafficking, calcium handling, and bioenergetics.
Selected Scientific Papers
- Roos, R. A. C. (2010). Huntington’s disease: a clinical review. Orphanet Journal of Rare Diseases.
- Banaszkiewicz, K., Sitek, E. J., Rudzinska, M., et al. (2012). Huntington’s disease from the patient, caregiver and physician perspectives. Psychiatry and Clinical Neurosciences (PMC).
- Olmedo-Saura, G., et al. (2025). Update on the symptomatic treatment of Huntington’s disease. International Journal of Molecular Sciences.
- Joshi, D. C., et al. (2025). The role of mitochondrial dysfunction in Huntington’s disease. Biomedicine & Pharmacotherapy.
Friedreich’s Ataxia
What is this disease?
Friedreich’s ataxia is an inherited disorder causing progressive loss of coordination, muscle weakness, and heart disease due to frataxin deficiency.
How it affects lifestyle
Mobility loss, scoliosis, and cardiomyopathy require wheelchairs, physical therapy, and cardiac monitoring from early adulthood.
Side effects of current treatments
Supportive care only; limited disease-modifying drugs exist for most patients.
The correlation between mitochondrial health and this disease
Very high correlation. Frataxin deficiency directly impairs mitochondrial iron-sulfur cluster assembly, causing severe OXPHOS defects and ROS overload.
Selected Scientific Papers
- Reetz, K., et al. (2025). Friedreich’s ataxia, a rare multisystem disease. The Lancet Neurology.
- Perlman, S., et al. (2025). The clinical burden of Friedreich ataxia in the United States. (journal article).
- Lynch, D. R., et al. (2021). Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Annals of Neurology.
- Vaubel, R. A., & Isaya, G. (2012). Iron–Sulfur Cluster Synthesis, Iron Homeostasis and Oxidative Stress in Friedreich Ataxia. (review, PMC).
निष्कर्ष
Mitochondrial health is no longer a niche idea. It is one of the clearest ways to understand why so many chronic conditions share the same underlying patterns. Many of the diseases on this page are linked by a common problem in cellular energy. When mitochondria struggle, the effects can spread across the body, disrupting metabolism, increasing oxidative stress, and making long-term health harder to protect.
At FMG Health Sciences, our focus is on this biology, and on the pathways that help cells maintain energy, resilience, and balance.
We created Mitochondria 101 as a living educational resource. Whether you are dealing with one of these conditions, supporting someone who is, or simply trying to better understand the role of cellular energy in health, this page is meant to be a starting point.
Mitochondrial science is moving fast, and its relevance to everyday health is becoming harder to ignore. We are committed to following that science responsibly, clearly, and with people at the center of it.